Cardiac sympathetic dysfunction in an athlete's heart detected by 123I-metaiodobenzylguanidine scintigraphy

Japanese Circulation Journal

Volumn 65, Issue 5, 2001, Pages 371-374

  Matsuo, Shinro ^a   Nakamura, Yasuyuki ^a   Takahashi, Masayuki ^a   Matsui, Toshiki ^a   Kusukawa, Junya ^a   Yoshida, Shintaro ^a   Hamamoto, Hajime ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Athlete's heart; H M; Iodine 123 labeled metaiodobenzylguanidine (MIBG) scintigraphy; Washout rate

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123;

ADULT; AGED; ARTICLE; ATHLETE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; HEART LEFT VENTRICLE MASS; HEART SCINTISCANNING; HUMAN; MALE; NERVE FUNCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC NERVE; VAGUS TONE;

3-IODOBENZYLGUANIDINE; ADULT; AGED; FEMALE; HEART; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; SPORTS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0035003007     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.65.371     Document Type: Article

References (21)

1. Matsuo S, Takahashi M, Nakamura Y, Kinoshita M: Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in patients with silent myocardial ischemia. J Nucl Med 1996; 37: 712-717
2. Miyanaga H, Yoneyama S, Kimitani T, Kawasaki S, Takahashi T, Kunishige H: Clinical usefulness of 1231-metaiodobenzylguanidine myocardial scintigraphy in diabetic patients with cardiac sympathetic nerve dysfunction. Jpn Circ J 1995; 59: 599-607
3. Matsuo S, Mitsunami K, Nakamura Y, Tsutamoto T, Yoshida S, Kusukawa J, et al: Evaluation of cardiac sympathetic nerve function in patients with hypertrophic cardiomyopathy using I-123 MIBG imaging (abstract). Ann Nucl Med 1996; 10: 256
4. Kurata C, Shouda S, Mikami T, Uehara A, Ishikawa K, Tawarahara K. et al: Metaiodobenzylguanidine and heart rate variability in heart failure. Jpn Circ J 1998; 62: 770-772
5. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathy. Br Heart J 1980; 44: 672-673
6. Matsuo S, Nakamura Y, Takahashi M, Mistunami K, Kinoshita M: Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia. Jpn Circ J 1998; 62: 167-172
7. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendation regarding quantitation in M-mode echocardiography: Result of a survey of echocardiographic measurements. Circulation 1978; 44: 1072-1083
8. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: Anatomic validation in the method. Circulation 1977; 55: 613-618
9. Sugihara H, Shiga K, Terada K, Kinoshita N, Taniguchi Y, Ito K, et al: Effect of exercise-induced activation of sympathetic nerve activity on cllearance of I-123 MIBG from the myocardium. Ann Nucl Med 1998; 12: 175-178
10. Vataco AR, Fleisher LA, Katzel LI: Heart rate variability and cardiovascular fitness in senior athletes. Am J Cardiol 1997; 80: 1389-1391
11. Williams R, Eden RS, Moll ME, Lester RM, Wallace AG: Autonomic mechanisms of training bradycardia: Beta-adrenergic receptors in humans. J Appl Physiol 1981; 51: 1232-1237
12. Glowniak J, Kilty J, Amara S, Hoffman BJ, Turner FE: Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med 1993; 34: 1140-1146
13. Estorch M, Camprecios M, Flotats A, Mari C, Berna L, Catafau AM, et al: Sympathetic reinnervation of cardiac allografts evaluated by I-123-MIBG imaging. J Nucl Med 1999; 40:911-916
14. Sakata K, Shirotani M, Yoshida H, Kurata C: Cardiac sympathetic nervous system in early essential hypertension assessed by I-123 MIBG. J Nucl Med 1999; 40: 6-11
15. Powers SK, Williams J: Exercise-induced hypoxaemia in healthy trained athletes. Sports Med 1987; 4: 46-53
16. Green LH, Cohen SI, Kurland G: Fatal myocardial infarction in marathon racing. Ann Intern Med 1976; 84: 704-706
17. Muntz KH, Hagler HK, Boulas J, Willerson JT, Buja LM: Redistribution of catecholamines in the ischemic zone of the dog heart. Am J Pathol 1954; 114: 64-78
18. Thames MD, Klopfenstein HS, Abboud FM, Mark AJ, Walker JL: Preferential distribution of inhibitory cardiac receptors with vagal afferents to the inferoposterior wall to the left ventricle activated during coronary occlusion in the dog. Circ Res 1978; 43: 512-519
19. Maron BJ: Sudden death in young athletes: Lessons from the Hank Gathers affair. N Engl J Med 1993; 329: 55-57
20. Schafers M, Wichter T, Lerch H, Matheja P, Kuwert T, Schafers K, et al: Cardiac 123I-MIBG uptake in idiopathic ventricular thachycardia and fibrillation. J Nucl Med 1999; 40: 1-5
21. Zehender M, Meinertz T, Keul J, Just H: ECG variants and cardiac arrhythmias in athletes: Clinical relevance and prognostic importance. Am Heart J 1990; 119: 1378-1391